Tag: RWD

By Vigilare Biopharma March 15, 2026Uncategorized

FDA Launches TEMPO What Medical Device Innovators Need to Know

Are you a medical device manufacturer working on digital therapeutics, remote monitoring tools, or AI-enabled care solutions for chronic disease management? If your innovation is outcome-based and driven by real-world data, you should pay close

Read More
By Vigilare Biopharma January 30, 2026Pharmacovigilance

Real-World Evidence (RWE) in Pharmacovigilance MAH Compliance and EMA’s 2026 Framework

The European Medicines Agency (EMA) is re-examining its approach to drug safety. The 2026 pharmacovigilance (PV) framework marks significant progress in using real-world evidence (RWE) to monitor medicines and inform regulatory decisions in the European

Read More